News Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023 Continue Reading Previous Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPDNext Accenture Invests in Open Cosmos to Expand Access to Satellite Data Related Stories News CORRECTION: Agereh Expands Intelligent Transportation Portfolio with Launch of Smart Door Sensor™ and retains Hillside C&M Inc. News Tai Software and OpenTrack Announce Integration Bringing AI-Native End-to-End Container Visibility Directly into Tai TMS News Joveo’s 2026 Recruiting Benchmarks Report Reveals Up to 9x Growth in Applicant Volume Over the Past Three Years News Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc. News SATO Technologies Corp. Provides Strategic Review and Operational Update News Collin Groves from BDev Ventures to Speak at TechCon Southwest 2026
